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The autosomal dominant formof retinitis pigmentosa (adRP) is a blindness-causing conformational dis-
ease largely linked to mutations of rhodopsin. Molecular simulations coupled to the graph-based pro-
tein structure network (PSN) analysis and in vitro experiments were conducted to determine the
effects of 33 adRP rhodopsin mutations on the structure and routing of the opsin protein. The integra-
tion of atomic and subcellular levels of analysis was accomplished by the linear correlation between
indices of mutational impairment in structure network and in routing. The graph-based index of struc-
tural perturbation served also to divide the mutants in four clusters, consistent with their differences
in subcellular localization and responses to 9-cis retinal. The stability core of opsin inferred from PSN
analysis was targeted by virtual screening of over 300,000 anionic compounds leading to the discov-
ery of a reversible orthosteric inhibitor of retinal bindingmore effective than retinal in improving rout-
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Conformational and misassembly diseases are disorders of protein folding, often due to missense muta-
tions, which compromise protein function (Sanders and Myers, 2004; Lin and Liu, 2006; Conn and Ulloa-
Aguirre, 2010). Potential pharmacological therapies for these diseases are based on promoting correct
folding, inhibiting aggregation, increasing degradation, or protection from cell death (Mendes and Chee-
tham, 2008; Mendes et al., 2005). Many diseases associated with misfolding and ER retention involve
membrane proteins, including G protein-coupled receptors (GPCRs) like rhodopsin (RHO) (Conn and
Ulloa-Aguirre, 2010; Sanders and Myers, 2004; Castro-Fernandez et al., 2005; Gregersen et al., 2006; Gre-
gersen, 2006; Mendes et al., 2005).
Most of the over 140 missense mutations found in RHO are linked to the autosomal dominant form of reti-
nitis pigmentosa (adRP) (Briscoe et al., 2004). Retinitis pigmentosa comprises a group of hereditary human
diseases that are the most common cause of inherited blindness in developed countries (Kennan et al.,
2005; Mendes et al., 2005). Themajority of adRP RHOmutants have been the subject of extensive biochem-
ical and cellular characterizations in heterologous expression systems and transgenic animals, leading to a
classification into three major groups (I, IIa/II, and IIb/III) (reviewed in Briscoe et al., 2004; Krebs et al., 2010).
Class I mutants resemble wild-type (WT) in yield, electrophoretic pattern, ability to regenerate with 11-cis
retinal, and subcellular localization. In contrast, class IIa (or II in Krebs et al., 2010) and class IIb (or III in Krebs
et al., 2010) mutants show altered membrane localization when expressed in cell culture in the absence of
retinal and compromised or uncompromised abilities, respectively, to regenerate with retinal in vitro (Table
S1). Another classification of RHO mutants linked to adRP and autosomal dominant congenital stationary
night blindness (adCSNB) accounted not only for ER retention and impairment in retinal binding (class 2)
but also for effects on other aspects of RHO function, such as post Golgi trafficking and outer segment tar-
geting (class 1), vesicular trafficking and endocytosis (class 3), post-translational modifications (class 4),
transducin activation (class 5), constitutive activity (class 6), and dimerization efficiency (class 7) (Mendes
et al., 2005; Athanasiou et al., 2018) (Table S1).
Almost 90% of the biochemically characterized adRP RHO mutants are likely to be misfolded (reviewed in
Briscoe et al., 2004; Krebs et al., 2010; Rakoczy et al., 2011; Athanasiou et al., 2018), supporting a protein-
misfolding disease model suitable for treatment with pharmacological chaperones, i.e., small moleculesiScience 4, 1–19, June 29, 2018 ª 2018 The Authors.
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Figure 1. AdRP Mutation Sites and Thermally Stable Structure Networks of RHO and OPS
(A–C) (A) The illustration of the crystal structure of dark RHO is shown. Like all GPCRs, OPS comprises an up-down bundle
of seven transmembrane helices (H) linked to three intracellular (IL) and three extracellular (EL) loops as well as to
extracellular and intracellular termini. The intracellular side is on top. Herein, H1, H2, H3, H4, H5, H6, and H7 are blue,
orange, green, pink, yellow, cyan, and violet, respectively. H8, the N- and C-termini are red, EL1 and IL1 are light green,
EL2 and IL2 are gray, and EL3 and IL3 are magenta. Mutated sites are represented as spheres centered on the Ca-atoms.
Black sticks represent 11-cis retinal. The stable structure networks of native RHO (B) and OPS (C) are shown on the crystal
structures (PDB: 1GZM and 3CAP, respectively). Labeled and black (retinal) spheres are the stable native hubs (i.e., those
amino acids involved in R4 links). Major structural differences between dark RHO and OPS essentially concern the
cytosolic half of the H5-H6 portion, in particular H6 that in OPS is tilted outward from the helix bundle by 6–7 A˚. See also
Tables S1, S2, and S3.that bind specific sites within a protein’s native or quasi-native structure, thereby shifting the folding equi-
librium toward the native state.
RHO is the visual pigment of rod photoreceptor cells that activates the phototransduction cascade
following light capture (Palczewski, 2006). It is composed of a protein opsin (OPS) and a chromophore,
11-cis retinal, forming a protonated Schiff base (PSB) with the amino acid residue K296 (Figure 1A) (Palczew-
ski, 2006). Opsins are densely packed into specific regions of the cell, the membranous discs of the rod
outer segment (ROS), which prevents their random diffusion and allows efficient absorption of light (Palc-
zewski, 2006; Kiser et al., 2014; Sakami et al., 2014; Fotiadis et al., 2003; Gunkel et al., 2015). Upon photon
absorption that causes the cis-trans isomerization of 11-cis retinal, RHO ultimately reaches the metarho-
dopsin II (MII) state able to activate the heterotrimeric G protein transducin (Gt), thus triggering the visual
phototransduction cascade (Hofmann et al., 2009).
RHO is the GPCR best characterized at atomic resolution in its inactive and active states. To date, high-res-
olution structures have been obtained for the dark state (Li et al., 2004; Palczewski et al., 2000), a number of
photo-intermediates (reviewed in Palczewski, 2006; Fanelli and De Benedetti, 2011), an active form of the
OPS apoprotein (Park et al., 2008), and the MII state (Choe et al., 2011).
The quantity of high-resolution information about the different RHO states makes this protein especially
suitable for deciphering the structural determinants of conformational diseases linked to GPCR muta-
tions. Indeed, understanding the molecular bases of such diseases requires the characterization of the
interacting forces that found the native state and that, if impaired, lead to misfolding. Advances in
that respect was made by our previous computational experiments that highlighted a number of adRP
mutations as likely impairing the structural stability of the second extracellular loop (EL2) (Felline
et al., 2009) and a number of highly connected amino acids in proximity to the retinal-binding site
and the G protein-binding regions (Fanelli and Seeber, 2010). The latter study relied on the combination
of mechanical unfolding simulations and protein structure network (PSN) analysis, a cutting-edge
approach to unravel different aspects of protein function, including folding and stability (Vishveshwara
et al., 2009; Fanelli et al., 2013).2 iScience 4, 1–19, June 29, 2018
In the present study, by integrating PSN analysis of novel molecular simulations with in vitro experiments,
we determined the effects of 33 different adRP mutations on the native structure network and on the sub-
cellular localization of both the RHO andOPS states. The putative stability core of the protein inferred from
the PSN analysis was targeted by virtual screening of compounds leading to the discovery of a potential
therapeutic agent as a pharmacological chaperone able to mitigate ER retention and restore plasmamem-
brane localization of three adRP mutants.
RESULTS
Local Perturbation at Mutation Sites
Molecular dynamics (MD) simulations of 33 adRP mutants in their apo and 11-cis retinal-bound states (Fig-
ure 1A, Table S2) were compared with those of the native RHO andOPS states. References on the discovery
and biochemical characterization of the mutants under study are provided in Briscoe et al., 2004; Krebs
et al., 2010; Rakoczy et al., 2011; Athanasiou et al., 2018.
Local perturbations induced by mutations displayed a variety of profiles (Table S2). Briefly, the N-terminus
mutation sites are located in structured portions (i.e., a b-hairpin for T4 and two different types of turns for
T17, P23, and Q28) and the mutations affect backbone conformation in addition to local side chain packing
interactions, whichmay contribute to variations in N-linked glycosylation as observed for the mutants at T4,
T17, and P23 (Tam and Moritz, 2009; Chen et al., 2014; Sakami et al., 2011). Effects on backbone conforma-
tion also arise from mutations of glycine, proline, and threonine in the helices (H) or in EL2.
Mutations in arginine often generate non-native salt bridges involving E25 or, more frequently, E122 or
E181 (shadowed in Table S2). The only case of arginine replacement, the R135W mutant, is characterized
by loss of the native salt bridges between R135 and both E134 and E247 and establishment of van derWaals
interactions between W135 and hydrophobic amino acids in H6 (shadowed in Table S2). It is worth noting
that R135 is the highly conserved arginine of the E/DRYmotif, an amino acid residue playing a central role in
G protein recognition as shown by X-ray crystallographic determinations (Scheerer et al., 2008; Rasmussen
et al., 2011). The R135W mutant was found to be hyperphosphorylated and bound with high affinity to the
visual protein arrestin (Chuang et al., 2004).
As for the threemutants characterized by an aspartate substitution (i.e. V87D,G89D, andG114D), the estab-
lishment of a non-native salt bridge concerns onlyD114 that, in the RHO form, acts as a counterion of the PSB
(shadowed in Table S2). Other perturbations may result in either breakage of native disulfide bridges
(C187Y), or formation of non-native disulfide bridges (Y178C), or both (C110Y) (shadowed in Table S2).
Structure Network-Based Characterization and Clustering of adRP Mutants
To determine similarities and differences between adRP mutants likely related to function despite the high
heterogeneity of the local perturbations at the mutation site, our study focused on the long-range propa-
gation of mutational effects. These were investigated by PSN analysis, which is based on the application of
graph theory to protein structures (Brinda and Vishveshwara, 2005; Fanelli et al., 2013). In a protein structure
graph (PSG), each amino acid is represented as a node and nodes are linked together based upon the
strength of their non-covalent interaction. Hyperlinked nodes are defined as hubs, and they are likely to
play a central role in protein stability. MD simulations of native OPS and RHO both at 300 K and at melting
conditions (i.e., 329 K for OPS and 345 K for RHO [Khan et al., 1991]) served to identify the most stable
(i.e., most persistent) structure network elements characterizing the native states.
To compute the native stable structure network, the frequencies of all hubs and links in the 300 K network
were averaged with the frequencies of the same hubs and links in the corresponding melting temperature
network (see Methods). Hubs and links holding an average frequency R50% were defined as stable and
included in the native network. Native stable hubs in RHO tend to occur in EL2 as well as in all helices except
for H1 and H4 (Figure 1B). EL2, H3, and H6 are particularly enriched in hubs, which include highly conserved
amino acids (R135, F261, W265, Y268, and Y306 [Mirzadegan et al., 2003]) as well as amino acids involved in
inter-helical interactions or in retinal binding (N78, E113, E122, W126, F203, H211, W265, Y268, and K296)
(Table S3). A significant part of these hubs (M44, T94, R135, P180, Q184, D190, H211, and K296) are sites of
pathogenic mutations (Briscoe et al., 2004). The chromophore is one of the most recurrent hubs (average
frequency, 91%). The absence of this hub in OPS results in a significant rearrangement of the structure
network (Figure 1C). Changes concern the loss of six stable hubs (from 23 to 17, Table S3) and 12 stableiScience 4, 1–19, June 29, 2018 3
links (from 194 to 182, Table S3) in OPS compared with RHO, which correlates with the lower melting tem-
perature of the former (Khan et al., 1991). While 76% of the native OPS stable hubs are retained in the RHO
state, native stable links undergo a more significant rearrangement following the addition of 11-cis retinal.
In fact, OPS and RHO share 106 stable links, whereas the number of links specific to one of the two forms is
76 for OPS and 88 for RHO (Table S3).
On this basis we used such network elements to describe and quantify likely structural differences between
each mutant and the two native states generated by the absence or presence of retinal. The differences in
structure networks betweenWT and mutants were effectively quantified using the following computational
index, network perturbation (NP):
MutNP = 100
0
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þ
PWThubstot
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:
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where Mutlinksmiss is the number of missing native stable links in the mutant network and WT
links
tot is the
total number of native stable links. WThubstot is the total number of native stable hubs and Mut
hubs
i
andWThubsi are the frequencies of native stable hubs i in the mutant and WT networks, respectively.
The higher the score, the greater the loss in native stable hubs and native stable links associated with
a given mutant. The NP score accounts for mutation-induced perturbations in the structure network
describing the native states of OPS and RHO.
The NP indices computed for OPS and RHO for each mutant (Figures 2A and 2B, respectively), and the differ-
ences between them (DNP, Figure 2C) were used to cluster the mutants (see Methods for details on clus-
tering), leading to four groups (Figure 2 and Table S4). Cluster 1 (white in Figures 2A–2C) groups the
mutants characterized by low NP in both OPS and RHO, as well as low DNP; cluster 2 (blue in Figures 2A–
2C) groups the mutants characterized by high and low NP in OPS and RHO, respectively, as well as high
DNP; cluster 4 (black in Figures 2A–2C) groups the mutants characterized by high NP in both OPS and
RHO as well as low DNP. Finally, for the members of cluster 3, the NP values are high in OPS, whereas they
tend to hold values between those of clusters 2 and 4 in RHO, resulting as well in intermediate DNP scores
(gray in Figures 2A–2C). On average, clusters 1 and 4 show, respectively, the lowest and highest destabilization
of the native structure network independent of the presence of 11-cis retinal, whereas cluster 2 resembles clus-
ter 4 in the absence of 11-cis retinal and cluster 1 in the presence of 11-cis retinal (Figure 2D). In other words, for
cluster 2 the presence of 11-cis retinal hinders structural impairments by the mutations.
In addition, a linear trend was observed between the NP index and a spectroscopic index from the litera-
ture that accounts for the degree of misfolding of RHOmutants as compared with WT (Figure S1) (Kaushal
and Khorana, 1994; Hwa et al., 1997, 1999; Iannaccone et al., 2006; Andres et al., 2003; Stojanovic et al.,
2003; Bhattacharya et al., 1992). This trend is consistent for eleven of the sixteenmutants for which the spec-
troscopic index could be determined. The spectroscopic index, which is the ratio between the absorbances
at 280 nm (due to tryptophan and aromatic residues in the protein) and at 500 nm (reflecting 11-cis retinal
binding), reflects the ratio between misfolded and folded (retinal-bound) protein. Since spectroscopic de-
terminations of the different mutants were not made by the same laboratory, we divided the absorbance
ratio (A280/A500) of a given mutant by that of the WT to normalize the indices. The WT index from the
different laboratories ranged from 1.6 to 2 (Table S5). For the mutants C110Y, G114D, C167R, P171Q,
Y178C, E181K, S186P, C187Y, D190Y, H211P, C222R, and P267L, some laboratories reported no detectable
absorbance at 500 nm, indicating the absence of retinal binding (Andres et al., 2003; Hwa et al., 1997, 1999;
Kaushal and Khorana, 1994). This agrees with the observation that most of those mutants fall in clusters 3
and 4 assigned in this study. Consistently, most mutants, for which the A280/A500 index could be deter-
mined, fall in cluster 1. Together these data suggest that the NP score is somehow related to a commonly
used index of RHO misfolding.
The selected NP is almost always the center of the three closest values obtained from different MD trajec-
tories. The use of the NP index relative to a single MD trajectory (at the two different temperatures) instead4 iScience 4, 1–19, June 29, 2018
Figure 2. Network Perturbation (NP) Score and Outer van der Waals Volume (Vout) of Retinal as Markers of Structural Mutational Effects
(A–C) Plots of the NP score for OPS (A) and RHO (B) and the difference between them (C) are shown. Colors indicate the four clusters obtained by using the
NP scores and the DNP between them. White, blue, gray, and black indicate clusters 1, 2, 3, and 4, respectively.
(D and E) (D) The average values of NPOPS, NP RHO, and DNP for each cluster of mutants are shown in a 3-axis plot that highlights the subdivision of the four
clusters. The outer van der Waals volume (Vout, A˚3) of 11-cis retinal in the average minimized structure of a given mutant relative to the 11-cis retinal van der
Waals volume in the average minimized structure of WT RHO is shown (E).
See also Tables S1, S4, and S5 and Figures S1 and S2.of an average value served to favor structural interpretability, while keeping the main inferences from the
analysis. Indeed, the results of cluster analysis do not change if they are based on the average NP values
(Figure S2).
In summary, we defined a structure graph-based index describing the perturbations induced by adRP mu-
tations on the native structure network of the OPS and RHO states. This index also served to divide the mu-
tants into four clusters accounting for the different structural responses to retinal, which is maximal for the
members of cluster 2.
Structural Signatures of the Four Clusters of adRP Mutants
The members of each cluster tend to share a common behavior in terms of 11-cis retinal deformation. The
latter is described by the retinal outer van der Waals volume (i.e., the size/shape descriptor Vout, see
Methods [De Benedetti and Fanelli, 2010; Fanelli and De Benedetti, 2011]) in a given mutant relative to
the retinal volume in WT RHO (Figure 2E). The higher the value of Vout, the greater the degree of retinal
deformation. As shown in Figure 2E and Table S4, cluster 1 and 2 mutants on average tend to show the
lowest Vout values, whereas cluster 4 mutants show the highest value.iScience 4, 1–19, June 29, 2018 5
Figure 3. Native Stable Links Weakened by Mutation
(A–H) Native stable links undergoing an average reduction in frequencyR25% within each cluster are shown on the crystal structures of OPS (A, C, E, and G)
and RHO (B, D, F, and H). Nodes and links are colored according to their average frequency reduction. Cyan, dark cyan, blue, and dark blue represent
average reductions up to 30%, 40%, 50%, and greater than 50%, respectively. See also Table S6.Signatures of each cluster, as inferred from the structure networks, are the native stable links that un-
dergo an average frequency reduction R25% in the mutant trajectories participating in the cluster (Fig-
ure 3 and Table S6). As for the extracellular half of the receptor where the retinal-binding site is located,
in the OPS state cluster 1 displays the lowest perturbation of native stable links compared with the other
three clusters in terms of reduction in number and frequency (Figure 3A). Remarkably, the presence
of 11-cis retinal prevents major perturbations shared in OPS by the members of cluster 1 and, more
prominently, of cluster 2 (Figures 3A–3D), whereas the chromophore is less effective for clusters 3 and
4 (Figures 3E–3H).
In the RHO state the members of cluster 4 share link weakening that spans the retinal-binding site to the
extreme N-terminus (Figures 3G and 3H) and involves (1) the links between E113 and both retinal and
K296; (2) the links between M288 and Y268, V271, and I275; (3) the links in the amino acid pairs
F9-F24, Q36-A32, T94-F293, S98-C185, C264-T297, and W265-A295; (4) the links between F283 and
both I275 and F287; and (5) the network involving P12, N200, V204, and the amino acid stretch
189–194 (Table S6).6 iScience 4, 1–19, June 29, 2018
As for the intracellular half of OPS, all clusters share reduction in frequency for several native links that
involve highly conserved amino acids and/or adRP mutation sites. These residues include N55 in H1,
L125 and the glutamate and arginine pair of the ERY motif in H3, Y223 in H5, F261 in H6, the NPxxY motif
in H7, and F313 in H8 (Figure 3 and Table S6). In contrast, in RHO all clusters share limited perturbation of
the native stable links in the intracellular half, likely related to a long-range effect of retinal, which is greatest
for the mutants in clusters 1 and 2 (Figure 3).
Collectively, all clusters show marked link destabilization in OPS as an effect of mutation on backbone and
side-chain structure and dynamics. Major structural differences among the four clusters reside in the extent
of the destabilization of native links in the extracellular half of the receptor and in the ability of 11-cis retinal
to hinder such perturbations. The structural chaperone effect of 11-cis retinal reaches a maximum for clus-
ter 2 and a minimum for cluster 4. The significant perturbation in the retinal-binding site, as highlighted by
retinal deformation, suggests that cluster 4 mutants share defects in retinal binding.
Retinal Effects on the Subcellular Localization of WT and Mutated OPS
In vitro experiments in parallel to computational experiments served to determine the subcellular localiza-
tion of WT and mutant OPS and RHO (Figure 4). The cDNAs were transiently transfected in COS-7 cells that
expressed proteins with expectedmolecular weights (Figure S3A and Table S4). The use of COS-7 cells was
dictated by the fact that no rod photoreceptor cell line is available that expresses rod photoreceptor
genes, acquires photoreceptor morphology, and forms an outer segment in vitro. Use of a cell line that
does not express OPS also allowed us to detect OPS in theWT andmutant forms using anti-OPS antibodies
without the need to add tags that may affect the subcellular localization of the protein.
The ability of 9-cis and 11-cis retinal to promote proper folding and trafficking has been previously
demonstrated for the adRP mutants P23H, T17M, and Q28H (Li et al., 1998; Noorwez et al., 2004,
2009; Mendes and Cheetham, 2008; Krebs et al., 2010; Kiser et al., 2014). Thus, in the present study, pro-
tein expression was carried out both in the absence and presence of 9-cis retinal. In cell culture, 9-cis
retinal is more stable than the 11-cis isomer and shows similar photoactivation properties making it a
good substitute (Palczewski, 2010; Kiser et al., 2014). The ER localization of OPS and RHO was quantified
by the Pearson correlation coefficients (PCC) for their co-localization with the ER-resident calnexin
(CLNX), a chaperon for WT and misfolded OPS (Figure S3B) (see Methods) (Kosmaoglou and Cheetham,
2008; Noorwez et al., 2009). For the WT and the G114D mutant additional confocal analyses were
performed to confirm the observed differences in the PCCs (Videos S1 and S2 and Supplemental Infor-
mation). Plasma membrane localization was assessed in the absence of cell permeabilization by a mono-
clonal antibody, RetP1, recognizing the extracellular N-terminus of the protein. Membrane integration of
the expressed proteins was quantified by the RetP1/1D4 ratios, where 1D4 is a monoclonal antibody
against the OPS C-terminus. The choice of cell lines does not change the outcome, as demonstrated
for the P23H mutant expressed in HeLa cells where similar values of PCC and RetP1/1D4 ratio were found
(Latella et al., 2016).
Most of the mutations cause increased OPS ER retention, as defined by co-localization with CLNX
(1D4/CLNX in Figure 4) and confirmed by a second ER marker (Figure S4), and drastically reduced plasma
membrane localization compared with the WT (RetP1 in Figure 4). Only five mutants (T4K, G51A, L125R,
V137M, and A164V) falling in cluster 1 exhibit WT-like localization. Thesemutants show little CLNX co-local-
ization (PCCs, 0.47–0.53) and are detected at the cell surface in nearly every OPS-expressing cell (RetP1/
1D4: 0.79–0.96), indicating that they are transported to the plasma membrane (Figure S5 and Table S4).
Cluster 1 mutants M44T, F45L, T58R, G89D, G106R, and C167R also show WT-like membrane localization
but with significantly higher PCCs (0.58–0.65) compared with the WT, indicating that these mutations may
cause partial ER retention, whereas most of the protein is properly located at the cell surface. Consistent
with the high PCCs, no plasmamembrane localization is observed for the mutants T17M, P23H, L46R, P53R,
C110Y, G114D, P171Q, Y178C, E181K, S186P, C187Y, G188R, D190G, D190Y, H211P, H211R, and C222R,
falling into clusters 2–4, which was not due to failure of the antibody to recognize misfoldedmutant protein
(Figure S6). Despite their high PCC values, Q28H, V87D, R135W, P180A, and P267L show some cells labeled
by the RetP1 antibody in the absence of membrane permeabilization, indicating that they are partially in-
tegrated at the plasma membrane (Figures 4 and S5). Compared with the WT, these mutants have drasti-
cally reduced RetP1/1D4 values (0.05–0.29), indicating that only a small fraction of the protein is transported
to the plasma membrane (Figure 5).iScience 4, 1–19, June 29, 2018 7
Figure 4. Subcellular Localization of All Analyzed OPS Mutants in the Absence and Presence of Retinal
Representative images of the WT and all analyzed OPS mutants in the absence and presence of 10 mM 9-cis retinal are
shown. 1D4/CLNX: merged image of the 1D4 (anti OPS/RHO intracellular C-terminus antibody, red) and the CLNX
(anti-ER antibody, green) staining; RetP1 (anti extracellular N-terminus antibody, red) staining. Scale bars, 50 mm. See also
Videos S1 and S2, Table S4, and Figures S3–S7.When expressed in the presence of 9-cis retinal, most of the mutants that exhibit strong ER retention in
OPS show significantly less CLNX co-localization and increased plasma membrane localization (Figures 4
and S5). Exposing transfected cells to all-trans retinal, on the other hand, has no effect on WT RHO,
the WT-like mutant G51A, and a subset of mutants that respond to 9-cis retinal, thus confirming
that the observed responses are specific for a conformation of the isomer capable of binding OPS
(Figure S7).
Subcellular localization of WT and mutants that show WT-like or only slight ER retention in the absence of
retinal do not significantly change when 9-cis retinal is present (Figures 4 and S5). The strongest effect of
retinal is observed for the mutants P171Q, T17M, E181K, V87D, R135W, D190Y, Q28H, P180A, and P267L,
falling into clusters 2 and 3 (Figure 2), which are characterized by a strong reduction in their PCCs and an
increase of their RetP1/1D4 values (Figures 4 and S5).8 iScience 4, 1–19, June 29, 2018
Among thesemutants, the best phenotypic rescues in terms of plasmamembrane localization are detected
for T17M and V87D that, exposed to 9-cis retinal, exhibit PCCs and RetP1/1D4 values similar toWT (Figures
S5C and S5D and Table S4). The mutant Q28H also shows WT-like CLNX co-localization, although this
mutant still has a slightly but significantly lower RetP1/1D4 value in the presence of 9-cis retinal (Figures
S5C and S5D and Table S4). The mutants P171Q, E181K, R135W, D190Y, P267L, and P180A show drastically
improved membrane localization with WT-like RetP1/1D4 values; however, all of them still have slightly
but significantly higher PCCs, indicating that the presence of 9-cis retinal does not completely mitigate
ER retention (Figures 4 and S5). Mutants S186P, D190G, Y178C, and P23H also respond to 9-cis retinal
with a significant increase in RetP1/1D4 values and a decrease in PCCs, although they still exhibit signifi-
cantly reduced membrane localization and strong CLNX co-localization, suggesting less effective pharma-
cological rescue (Figures 4, S5C, and S5D). As for the remaining mutants, which all fall in cluster 4, the three
mutants G188R, C222R, and H221P show minimal responses to 9-cis retinal in terms of membrane localiza-
tion (C222R and H221P) or ER retention (G188R). ER retention of mutants L46R, P53R, C110Y, G114D,
C187Y, and H211R could not be mitigated by 9-cis retinal (Figures 4 and S5).
Comparison of the PCC-RetP1/1D4 correlation plots in the absence (Figure S5E) and presence (Figure S5F)
of 9-cis retinal shows that the chromophore drastically improves plasma membrane localization and re-
duces ER retention in a large subset of mutants. However, most of these mutants still exhibit higher ER
localization than the WT, indicating that 9-cis retinal can improve proper transport but it does not fully
restore the WT phenotype for many of the mutants.
Importantly, for both the OPS and RHO states, the PCC index correlates linearly with either selected or
average NP scores accounting for mutation-induced impairment in the native structure network (Figures
5 and S1). The correlation is such that the NP-based clustering produces the same results if based on
PCC, implying a connection between defects in structure and sub-cellular localization.
Structure-Based Discovery of a Pharmacological Chaperone Targeting the Stability Core of the
OPS Protein
Structure network analysis indicated that the retinal-binding site is part of the stability core of the protein
since most of the native links and hubs undergoing weakening as an effect of misfolding adRP mutations
locate in that region. This inference, together with the linear correlation found between mutational impair-
ment in the native structure network and ER retention, highlights the retinal-binding site as a suitable target
for virtual screening to discover small chaperones, i.e., pharmacological chaperones able to improve the
folding and routing of adRP mutants. A library of negatively charged compounds from the ZINC database
(http://zinc.docking.org/[Irwin and Shoichet, 2005; Irwin et al., 2012] see Methods) was computationallyFigure 5. Linear Correlation between NP and PCC
(A and B) The scatterplots show the linear correlation between the NP accounting for mutational effects on the native
structure network and the PCC index accounting for ER retention in the OPS (A) and RHO (B) states. The linear regression
equations are PCC = 0.014NP + 0.071, r = 0.932 for OPS and PCC = 0.012NP + 0.273, r = 0.938 for RHO. The error-
weighted correlation coefficients are 0.910 for OPS and 0.960 for RHO. The colors of circles reflect the structural cluster
assignment for each mutant (see the legend to Figure 2). See also Figure S2.
iScience 4, 1–19, June 29, 2018 9
In Vitro Effect T17M P23H E181K
EC50Ret EC50ERA EC50Ret EC50ERA EC50Ret EC50ERA
PCC 8.0 9.8 17.3 9.3 9.4 4.5
RetP1/1D4 5.4 4.6 8.0 4.8 1.1 0.5
Table 1. EC50 Values with Respect to PCC and RetP1/1D4 Immunostaining Comparing 9-cis Retinal and 13-cis-5,8-ERA
EC50Ret and EC50ERA are, respectively, the mM EC50 values of 9-cis retinal and 13-cis-5,8-ERA relative to ER retention (accounted for by PCC) and plasma mem-
brane localization (accounted for by RetP1/1D4 immunostaining) of T17M, P23H, and E181K mutants. A mixture of four optical isomers of 13-cis-5,8-ERA was
employed in EC50 determinations. See also Table S7.screened against the retinal-binding site using the Glide software (Friesner et al., 2004, 2006). Compounds
were primarily filtered according to the docking score leading to one hit list (made of 1,000 compounds) per
docking run (i.e., onto different structures). Vdif served as an additional index to select compounds that in
addition to a relatively good docking score had a relatively high Vdif relative to 11-cis retinal (seeMethods).
It is worth noting that volume comparisons were performed for compounds taken in their docking/interac-
tion mode with the protein. The index therefore accounts both for shape similarity between each ligand
and 11-cis retinal and for their degree of overlap in the binding site (see Methods). In this respect, Vdif
cannot be considered a canonical ligand-based index.
Twenty compounds (Table S7) of a list of 254 hits checked for commercial availability were probed in vitro
for their ability to favor plasma membrane localization of T17M, the mutant from cluster 2 most responsive
to retinal. Like retinal, all the selected compounds except one had predicted octanol/water partition co-
efficients, i.e., xlogP,R 5 (the xlogP of 11-cis retinal is 5.80 [http://zinc.docking.org/]).
The same experimental conditions as those used in this study to test the effects of 9-cis retinal were
applied for in vitro compound screening. One compound, 5,8-epoxy-13-cis retinoic acid (hereafter named
13-cis-5,8-ERA [Table 1], compound 1 in Table S7) was able to mitigate ER retention and promote plasma
membrane localization of T17M (Figure 6A). The PCC and RetP1/1D4 indices in the presence of 10 mM
13-cis-5,8-ERA are, respectively, 0.50 and 0.60, similar to 9-cis retinal, 0.46 and 0.59 (Tables S8 and S9).
The 13-cis-5,8-ERA, which comprises a mixture of commercially available optical isomers (i.e., 5S8R, 5R8S,
5R8R, and 5S8S), proved effective as a pharmacological chaperone also for the P23H mutant from cluster 3
(Figure 6B) and another mutant from cluster 2, E181K (Figure 6C). P23H was tested because it is the adRP
mutant most studied in vivo (Comitato et al., 2016; Sakami et al., 2011, 2014; Chiang et al., 2015), whereas
E181K was selected for testing based on the hypothesis that the substituting lysine would stabilize the pro-
tein-chaperone complex through an additional intermolecular salt bridge.
The Tanimoto coefficient (based on RDKit circular Morgan fingerprints [1,024 bits]) accounting for the sim-
ilarity between 13-cis-5,8-ERA and 11-cis retinal is 0.588 (Table S7), which is lower than the cutoff suitable to
cluster compounds according to chemical similarity. Thus, according to the Tanimoto coefficient, among
the 20 selected compounds, 13-cis-5,8-ERA is themost similar to 11-cis retinal; however, the similarity is not
so striking as also indicated by the Vdif index.
To quantitatively compare the pharmacological chaperone activity of 13-cis-5,8-ERA with that of 9-cis
retinal, for the three adRP mutants the EC50 values were computed relative to the PCC and RetP1/1D410 iScience 4, 1–19, June 29, 2018
Figure 6. Effects of 13-cis-5,8-ERA on Three Mutants
(A–C) Representative immunofluorescence images depicting the subcellular localization of T17M (A), P23H (B), and E181K
(C) mutants in the OPS state (i.e. - 9-cis retinal), in the presence of 10 mM 9-cis retinal, and in the presence of 10 mM 13-cis-
5,8-ERA. CLNX/1D4: merged image of the anti-CLNX antibody staining (green) and the anti-OPS/RHO 1D4 antibody
staining against the intracellular C-terminus (red); RetP1: staining of membrane localized OPS/RHO with the RetP1
antibody against the extracellular N-terminus. Scale bars, 50 mm.
(D–I) COS-7 transfected cells were exposed to different concentrations of 9-cis retinal (black circles) or 13-cis-5,8-ERA
(black squares). Values are the means (GSD) from the analysis of at least ten transfected cells from three independent
experiments. PCC values were derived from the analysis of co-localization of calnexin and OPS/RHO (CLNX/1D4) for the
T17M (D), P23H (E), and E181K (F) mutants. Ratios of RetP1-positive cells and 1D4-positive cells were computed for the
T17M (G), P23H (H), and E181K (I) mutants.
See also Table S8.indices (Figures 6D–6I and Table S8). The 13-cis-5,8-ERA compound is slightly less effective than 9-cis
retinal toward the T17M mutant, especially with regard to the effect on ER retention (Table 1 and Figures
6D and 6G), whereas its effectiveness toward P23H and E181K is 2-fold higher than that of 9-cis retinal both
in mitigating ER retention (Table 1 and Figures 6E and 6F) and promoting plasma membrane localization
(Table 1 and Figures 6H and 6I).
The 13-cis-5,8-ERA from the screened library corresponds to the 5S8R isomer. To better characterize the
effect of the compound on the native structure network of the protein, the other three isomers were docked
into the retinal-binding site as well. The complexes between WT and mutated forms and the four distinct
isomers were subjected to MD simulation and PSN analysis, following the protocol set in this study. In all
complexes, the carboxylate of 13-cis-5,8-ERA establishes charge-reinforced H-bonds with S186 (in EL2),
Y268 (in H6), and K296 (in H7) (Figures 7, S8, and S9). A peculiarity of the E181K mutant is the formation
of an additional salt bridge between the substituting amino acid and the carboxylate of the ligand (Figures
S8 and S9). The olefinic chain of the ligand makes van der Waals interactions with I189 (in EL2) and Y268
(in H6). Finally, the bicyclic moiety of the ligand occupies the same site as the b-ionone ring of retinal, mak-
ing van derWaals interactions withM207, F208, F210 (all in H5), andW265 (in H6). There is consistency in the
interaction mode regarding the carboxylate end of the ligand, whereas major divergences among the fouriScience 4, 1–19, June 29, 2018 11
Figure 7. Effects of 13-cis-5,8-ERA on the Native Structure Network
(A–I) Native stable links undergoing reduction in frequencyR25% are shown in the T17M (A, B, and C), P23H (D, E, and F),
and E181K (G, H, and I) adRP mutants. Panels A, D, and G portray the OPS state; panels B, E, and H illustrate the RHO
state; and panels C, F, and I show the 13-cis-5,8-ERA-bound forms. For each mutant, the native stable links in the
complexes with the four isomers of 13-cis-5,8-ERA that undergo an average reduction in frequencyR25% are shown.
Cyan, dark cyan, blue, and dark blue represent average reductions up to 30%, 40%, 50%, and greater than 50%,
respectively. Perturbed links are mapped onto the average minimized structures from 300 K simulations. As for the 13-cis-
5,8-ERA-bound forms, perturbed links are mapped onto the average minimized structure of the complexes with the 5S8R
isomer. All four isomers are represented by sticks and extracted from the respective averageminimized structures (5S8R is
green, 5R8S is yellow, 5R8R is violet, and 5S8S is pink). See also Figures S8 and S9.isomers occur at the bicyclic end. Collectively, while occupying the same binding site, 13-cis-5,8-ERA and
11-cis retinal display divergent interactions (Figure S9).
To mimic in vitro determinations, which were carried out on a mixture of isomers, the structural chaperone ef-
fect of 13-cis-5,8-ERA on T17M, P23H, and E181K mutants was described by an NP score averaged over
the scores of the single isomers, i.e., 25 G 4.54 for T17M, 32.91 G 4.66 for P23H, and 26.35 G 4.12 for
E181K. The averageNP scores of the new compound relative to the threemutants are consistent with the effect
of the compound on ER retention as accounted for by PCC. In line with the demonstrated ability of 13-cis-5,8-
ERA to relieve ER retention and improve plasma membrane localization for all three mutants, the number of12 iScience 4, 1–19, June 29, 2018
Figure 8. 13-cis-5,8-ERA Binding to Bovine Opsin
(A and B) Changes in tryptophan fluorescence at 332 nm (DF/F0) with increasing concentrations of 9-cis retinal (A) or
13-cis-5,8-ERA (B). Results are expressed as the mean G SD, n = 2, each with three biological replicates.
(C and D) UV-visible absorption spectra measured at 4 min after 9-cis retinal addition (C) and time-dependent absorption
at 487 nm (D) showing the effect of 13-cis-5,8-ERA pre-treatment on the formation of iso-rhodopsin pigment. Results are
expressed as the mean G SD, n = 2, each with three biological replicates. OPS membranes treated with 7.5 mM 9-cis
retinal for 4 min showed a new absorption peak at 487 nm owing to the formation of iso-rhodopsin pigment (red). A
decrease in iso-rhodopsin formation and regeneration rate was observed when OPS membranes were pre-treated with
37.5 mM of 13-cis-5,8-ERA for 15 min (purple) followed by the addition of 7.5 mM 9-cis retinal.native links undergoing a reduction in frequencyR25% is significantly lower in the presence of the compound
compared with the OPS state (Figure 7). For P23H and E181K, the average structural chaperone effect of the
four isomers is greater than that of retinal, in line with in vitro EC50 determinations (Figures 6 and 7).
To validate the predictions from computational experiments that 13-cis-5,8-ERA docks at the retinal-bind-
ing site, the binding of the compound to OPS was evaluated by monitoring the changes in OPS tryptophan
(Trp) fluorescence with varied concentrations of the ligand. The changes in the Trp fluorescence reflect the
conformational changes in the chromophore-binding pocket induced upon ligand binding (Farrens and
Khorana, 1995). A typical quenching of fluorescence associated with W265 was noted upon treatment
with increasing concentrations of 9-cis retinal (Figure 8A). 13-cis-5,8-ERA displayed a similar quenching
pattern (Figure 8B). This finding suggests that 13-cis-5,8-ERA either binds to the chromophore-binding
pocket or exerts an allosteric binding affect that can lead to conformational changes in the chromo-
phore-binding pocket. The EC50 of 13-cis-5,8-ERA to OPS (8.6 G 0.2 nM) was 14-fold lower compared
with 9-cis retinal (123.9 G 7.0 nM) (Figures 8A and 8B). Additionally, we tested the effect of 13-cis-5,8-
ERA on the regeneration rate of iso-rhodopsin pigment by using time-dependent UV-Vis spectroscopy.
As expected, addition of 9-cis-retinal to OPS membranes resulted in the Schiff base formation (lmax =
487 nm) between 9-cis retinal and K296 (Figure 8C, red trace). However, pre-treatment of OPS membranes
with 10 molar excess of 13-cis-5,8-ERA resulted in a significant decrease in both the iso-rhodopsin regen-
eration rates (t1/2 = 3.4233G 0.716 min compared with 1.3694 G 0.848 min for 9-cis retinal) and the total
iso-rhodopsin formation (88.04 G 2.39% relative to 9-cis retinal alone) (Figures 8C and 8D). The ability ofiScience 4, 1–19, June 29, 2018 13
9-cis retinal to bind 13-cis-5,8-ERA pre-treated OPS and to form iso-rhodopsin pigment suggests a revers-
ible binding of 13-cis-5,8-ERA to the protein. Overall, these findings suggest that 13-cis-5,8-ERA induces a
conformational change in the OPS chromophore-binding pocket and might compete with 9-cis-retinal for
OPS binding.
In summary, virtual screening of compound libraries led to the discovery of a pharmacological chaperone
more effective than retinal toward three adRP mutants selected from the most responsive clusters. The
compound was not revealed by previous virtual screening of the same proteins, owing to different compu-
tational conditions and the selected libraries (Noorwez et al., 2008). The ability of the novel chaperone to
relieve perturbations in the native structure network is consistent with its ability to correct routing of the
mutated protein. The combination of molecular simulations, sub-cellular localization by immunohisto-
chemistry, and binding detection by biophysical assays indicates that the chaperone activity of 13-cis-
5,8-ERA is due to the establishment of distinct intermolecular interactions with amino acids in the
retinal-binding site.DISCUSSION
Retinitis pigmentosa is a composite of varied retinal dystrophies most frequently leading to inherited blind-
ness. Although progress has been made in understanding the genetic basis of the disease, the develop-
ment of effective therapeutic interventions is still lacking. adRP linked to mutations in the GPCR RHO
are part of the family of conformational diseases, whose structural determinants are still unknown (reviewed
in Conn and Ulloa-Aguirre, 2010).
Pharmacological chaperones are promising therapeutic agents for the treatment of misfolding diseases
linked tomissensemutations. They consist of small molecules that enter cells, specifically bind tomisfolded
mutant proteins, and stabilize them in a conformational state that allows passing ER quality control systems
(Conn and Ulloa-Aguirre, 2010; Ulloa-Aguirre et al., 2004; Bernier et al., 2004). The discovery and develop-
ment of such therapeutic agents cannot be accomplished without significant knowledge of the structural
defects engendered by the various mutations.
In the present study, WT and 33 adRP mutants were subjected to parallel in silico and in vitro experiments
aimed at characterizing and quantifying mutational effects on structural stability and ER retention of the
protein, ultimately establishing a connection between the two distinct levels of analysis. The working hy-
pothesis motivating our computational experiments is that adRP mutants classified as misfolded indeed
represent ‘‘quasi-native’’ states of OPS.
The analysis of molecular simulations relied on structure network parameters (i.e., hubs and links) as a
strategy to study issues of protein structure instability likely pertaining to conformational diseases
(Fanelli and Seeber, 2010). In this context, equilibrium MD simulations at 300 K and melting temperatures
were instrumental in investigating mutational effects on the native structure networks of the RHO and
OPS states. Employing the native structure network as a frame of reference helped to describe muta-
tional effects in terms of quantifiable impairments in the intramolecular interactions characterizing the
native state. We observed that in the absence of 11-cis retinal the majority of the 33 adRP mutants
show marked impairment in stable native hubs and links as an effect of mutation on the backbone
and side-chain structures and dynamics. In the presence of 11-cis retinal, such perturbations decrease
significantly for a subset of mutants. This agrees with other evidence that OPS is less stable than RHO
even in the native state (Khan et al., 1991). A computational index, NP, quantifying mutation-induced
impairment in the native structure networks of both OPS and RHO served to structurally classify the
33 different mutants. Such clustering permitted the identification of common structural traits despite
different mutations. Those traits were embodied in those native links that become less stable as an effect
of mutation. These signatures are crude in that they depict an average behavior, with the understanding
that each mutant has its own structural distinctions. Yet, we preferred to focus on common structural ef-
fects of mutations from the same cluster to achieve a structure-based classification of adRP mutants with
therapeutic implications.
In vitro experiments served to determine the subcellular localization of WT and mutant forms of OPS in the
absence and presence of 9-cis retinal, which led to the development of an index of ER retention (PCC)
based on co-localization of OPS/RHO and calnexin. The finding of a linear correlation between NP and14 iScience 4, 1–19, June 29, 2018
PCC indices led us to associate the structural signatures of each cluster of mutants with the tendency to-
ward ER retention, an important step toward connecting defects in structure and sub-cellular localization.
Indeed, in the OPS state, cluster 1 mutants tend to share the lowest hub and link weakening compared with
the other clusters, especially in the extracellular regions, which may relate to their lowest ER retention and
highest plasma membrane localization compared with the other mutants. Marked ER retention and low
plasma membrane localization for clusters 2, 3, and 4 are instead associated with hub and link weakening
in both the extracellular and intracellular portions. The distinction between these three clusters, with
emphasis on clusters 2 and 4, essentially relies on the effect of retinal. The in vitro chaperone effect of
retinal on cluster 2 mutants is likely related to the ability of the chromophore to prevent major mutational
effects on the native structure network. In comparison, the inability of retinal to exert a chaperone effect for
cluster 4 mutants is likely due to the inability of the chromophore to properly bind and establish native con-
nections with the protein. Indeed, for these mutants link weakening involves the retinal itself, core-facing
nodes in the extracellular regions of H2 (T94 and S98), H3 (E113 and T118), H5 (F203 and V204), H6 (C264,
W265, Y268, V271, and I275), and H7 (P287, M288, F293, A295, K296, and T297), as well as nodes on both the
N-terminus (T4, F9, P12, N15, V20, F24, Y30, A32) and EL2 (W175, P180, K181, C185, P186, I189, D190, Y191,
Y192, T193, P194, and N200). Previously, some of these residues had been predicted to participate in the
stability core of the protein (Rader et al., 2004). Link weakening in the retinal-binding site for cluster 4 mu-
tants nicely relates to retinal deformation as indicated by the Vout size/shape descriptor, thus strength-
ening the hypothesis that retinal cannot bind such mutants properly in line with early in vitro evidence
from retinal reconstitution experiments (reviewed in Briscoe et al., 2004; Krebs et al., 2010; Rakoczy
et al., 2011; Athanasiou et al., 2018). The structural and cellular behaviors of cluster 3 mutants lie between
those of clusters 2 and 4.
Thus the integration of atomic and sub-cellular levels of analysis led to the finding that the structural sta-
bility of the protein, impaired as an effect of mutations, correlated with ER retention. The quantitative rela-
tion between structural deviation from the native state and ER retention is of remarkable value since ER
retention has been correlated with the pathological phenotype in published studies, although limited to
a subset of themutants analyzed here (Kosmaoglou et al., 2009; Krebs et al., 2010; Griciuc et al., 2011; Com-
itato et al., 2016).
The correlation between NP and PCC scores implies that the classification of mutants based on their
structural impairment is consistent with the classification based on their ER retention. Mutational ef-
fects on ER retention and the ability of OPS to bind retinal underlie earlier classifications of adRP
RHO mutants (reviewed in Briscoe et al., 2004; Krebs et al., 2010). Our in vitro data on the OPS states
are substantially in agreement with previous characterizations of subcellular localization in the absence
of retinal (reviewed in Briscoe et al., 2004; Krebs et al., 2010). Apparent discrepancies regard two mu-
tants (L125R and C167R) assigned to Krebs class II but localized at the membrane in this study and one
mutant (L46R) assigned to class I but retained in the ER in this study. In contrast, few discrepancies
concern the response to retinal that relies on a completely different approach in the present study. Pre-
vious studies evaluated the ability of the protein to regenerate with retinal, as detected by spectro-
scopic analyses, whereas the present study evaluated the ability of retinal to influence the subcellular
localization of the mutants. In this study, five (P171Q, Y178C, E181K, S186P, and D190Y) of eleven
(C110Y, G114D, P171Q, Y178C, E181K, S186P, C187Y, D190Y, H211P, H211R, and C222R) mutants
previously found incapable of binding retinal (Krebs et al., 2010) were localized in the ER in the OPS
form but could improve their plasma membrane distribution and relieve ER retention as an effect of
retinal.
Another classification, which has been recently updated, divides RHO mutants into seven classes (classes
1–7). Class 2 encompasses those mutants considered as misfolded because of their ER retention and
inability to reconstitute with retinal, whereas the other classes contain mutants thought to be properly
folded but impaired in different aspects of function (Athanasiou et al., 2018). Consistently, cluster 2, 3,
and 4 mutants from this study, which are retained in the ER at least in their OPS form, fell into class 2.
Consistency was also found for a number of mutants in our clusters 1 and 2, which fall in classes 3
(R135W), 4 (T4K and T17M), 5 (M44T and V137M), and 7 (F45L) by Athanasiou and co-workers and include
also a mutant considered as a benign single mutant polymorphism (G51A) (Athanasiou et al., 2018).
Indeed, for such mutants that show plasma membrane localization at least in their RHO form, defects
other than ER retention may cause the pathologic phenotype. In contrast, six of the eleven mutants iniScience 4, 1–19, June 29, 2018 15
our cluster 1 (T58R, G89D, G106R, L125R, A164V, C167R), which are moderately retained in the ER in the
OPS form, are considered misfolded by Athanasiou and co-workers and ascribed to class 2 (Athanasiou
et al., 2018).
Early mass spectrometry determinations on four adRP mutants postulated partial (for G89D and A164V)
or complete (for L125R and P211H) misfolding of OPS owing to the formation of a non-native disulfide
bridge between C185 and C187 in EL2 (Hwa et al., 2001). Three of those mutants fall on our cluster 1,
suggesting that, if present, such an intra-loop disulfide bridge would remain compatible with a protein
quasi-native state properly targeted to the plasma membrane.
Collectively, this investigation revealed some retinal responsiveness in themajority of the 33 adRPmutants,
including a number of mutants previously classified as misfolded. This supports our working hypothesis
that such mutants indeed represent quasi-native states of the OPS protein still capable of binding retinal.
The results of the integrated in silico and in vitro analyses suggest that ER retention and compromised
plasma membrane localization of OPS are related to the loss or weakening of native connections involving
the retinal-binding site as well as highly conserved nodes in the cytosolic regions. These findings support a
structural communication wherebymutations exert long-range destabilizing effects on common nodes and
links in the structure network necessary for the stability of the protein. Therefore, the putative stability core
of the protein inferred from PSN analysis was targeted by virtual screening of over 300,000 anionic
compounds. Mutant clusters based on structure network impairment were exploited to select three
retinal-responsive mutants, i.e., T17M, P23H, and E181K from clusters 2 and 3, for in vitro analyses. One
compound, an oxidation product of the 13-cis retinoic acid (Liang et al., 2003), 13-cis-5,8-ERA, of 20 tested
compounds proved able to relieve ER retention and favor the plasma membrane localization of all three
mutants. For E181K and, to a lesser extent, P23H, the pharmacological chaperone action of 13-cis-5,8-
ERA was 2-fold greater than that of 9-cis retinal. For the E181K mutant, the enhanced effect may be due,
at least in part, to the formation of an additional intermolecular salt bridge between the substituting lysine
and the carboxylate of the ligand. The chaperone action of 13-cis-5,8-ERA is likely due to its ability to sta-
bilize OPS by occupying in a reversible manner the retinal-binding site. The compound was tested as a
mixture of four optical isomers reflecting the presence of two chiral centers on the condensed bicyclic
group. MD simulations of the four distinct isomers toward the three mutants revealed divergences solely
in the binding mode of the bicyclic moiety, the carboxylic site showing overlapping binding modes in the
different isomers. This suggests that isomer separation may lead to some improvement in the chaperone
activity of the compound. The average effect of the four isomers on relieving native link weakening caused
by the mutation is in line with in vitro observations, thus highlighting the ability of the graph-based
approach to infer the structural bases of conformational diseases linked to missense mutations.
In summary, ER retention and compromised plasma membrane localization shared by most of the mutants
considered in this study are related to the loss or weakening of native intramolecular interactions involving
the retinal-binding site as well as highly conserved amino acids in the cytosolic regions. These structural
effects can be variably attenuated by retinal unless perturbations cause significant deformations in the
retinal-binding site thus compromising proper binding of the chromophore. Several adRP mutants, espe-
cially those in clusters 2 and 3, are amenable to treatment with pharmacological chaperones that limit ER
retention and subsequent ER stress by improving structural stability and routing of OPS. Together these
data suggest that the majority of the ER-retained adRP RHO mutants considered in this study hold
‘‘quasi-native’’ structures that can be stabilized by small compounds able to establish specific interactions
with the retinal-binding site. On this basis, by targeting the putative stability core of the protein, we discov-
ered a reversible orthosteric inhibitor of retinal binding able to correct the misrouting of three adRP mu-
tants from clusters 2 and 3, T17M, P23H, and E181K. For P23H and E181K the compound is more effective
than 9-cis retinal as a chaperone. Virtual screening allowed reduction by more than four orders of magni-
tude the number of compounds necessary for in vitro testing, ultimately leading to the discovery of a prom-
ising pharmacological chaperone from more than 300,000 compounds screened in silico and 20 com-
pounds screened in vitro.
The present study generated the tools for discovering and designing small compounds able tomitigate the
structural destabilization caused by misfolding mutations. A promising pharmacological chaperone has
been discovered, which holds the potential to be translated into a therapeutic agent for adRP linked to16 iScience 4, 1–19, June 29, 2018
RHO mutations. The comprehensive analysis of adRP mutations derived from this study also may be valu-
able for researchers developing new therapeutic approaches based on small chaperones. The strategy
described here to discover a small chaperone can be applied to various conformational diseases linked
to missense mutations of proteins with known structure.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods, nine figures, nine tables, and two videos and can
be found with this article online at https://doi.org/10.1016/j.isci.2018.05.001.
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Figure	S1	(related	to	Figure	2).	Linear	correlation	between	the	NP	score	computed	for	the	RHO	
state	and	the	spectroscopic	A280/A500	index.	The	linear	regression	equation	is	A280/A500	=	0.035NP	
+	0.461,	r	=	0.84.	The	colors	of	the	circles	reflect	the	assignment	of	mutants	to	different	structural	
clusters	(see	the	legend	to	Figure	2).	
	 	
	3	
	
	
Figure	S2	(related	to	Figures	2	and	5).	Mutant	clustering	based	on	the	average	NP	scores.	Plots	of	
the	NP	scores	averaged	over	 three	values	derived	 from	 independent	simulations	of	OPS	 (A)	and	
RHO	(B),	and	the	difference	between	them	(ΔNP	(C))	are	shown.	Colors	indicate	the	four	clusters	
obtained	by	using	the	average	NP	scores	and	the	Δ	between	them.	White,	blue,	gray,	and	black	
indicate,	respectively,	clusters	1,	2,	3,	and	4.	(D)	The	average	of	the	members	of	a	cluster	based	on	
NPs	is	shown	for	OPS	and	RHO.	The	linear	correlations	between	average	NP	score	and	PCC	for	OPS	
(E)	and	RHO	(F)	states	are	also	shown.		The	linear	regression	equations	are	PCC	=	0.015	average	NP	
+	0.033,	r	=	0.900,	for	OPS,	and	PCC	=	0.014	average	NP	+	0.215,	r	=	0.950,	for	RHO.	The	colors	of	
the	 circles	 reflect	 the	 assignment	 of	mutants	 to	 different	 structural	 clusters	 (see	 the	 legend	 to	
Figure	2).	
	
	4	
	
	
Figure	S3	(related	to	Figure	4).	Immunoblot	and	OPS/CLNX-colocalization	analyses	of	COS7	cells	
transiently	transfected	with	WT	or	mutant	OPS.	(A)	Immunoblot	analysis	of	WT	OPS	and	mutants	
T17M,	G51A,	G114D,	P171Q	and	P180A.	Equal	amounts	of	protein	extracts	from	cells	expressing	
WT	or	mutant	OPS	were	subjected	to	western	blot	analysis	and	probed	using	the	1D4	antibody	as	
described	previously	(Komolov	et	al.,	Anal	Bioanal	Chem,	397,	2967	(2010)).	RHO	extracted	from	a	
human	donor	 retina	 (lane	C),	COS-expressed	WT,	and	mutants	G51A,	G114D,	P171Q	and	P180A	
run	at	molecular	mass	values	of	~36	kDa	independent	of	the	presence	(+)	or	absence	(-)	of	retinal		
(black	 arrow).	 The	 lower	molecular	weight	 band	of	 T17M	 (white	 arrow)	most	 likely	 reflects	 the	
previously	described	glycosylation	 status	of	OPS	 (Tam	and	Moritz,	 J	Neurosci,	29,	 15145	 (2009).	
Anti-Neomycin	 Phosphotransferase	 2	 expression	 was	 used	 as	 a	 control	 of	 the	 transfection	
efficiency	for	WT	and	mutant	OPS	(gray	arrow).	(B)	Examples	of	OPS/CLNX-colocalization	analyses	
in	 COS7	 cells	 transiently	 transfected	 with	 WT	 (left	 panel)	 or	 mutant	 G114D	 OPS	 (right	 panel)	
constructs.	 Red/green:	 merged	 anti-OPS	 (1D4	 antibody,	 red)	 and	 anti-CLNX	 (green)	
immunofluorescence	images	showing	low	(WT)	and	high	(G114D)	PCC-values	respectively.	Green:	
green	 channels	 showing	 the	 corresponding	 anti-CLNX	 immunofluorescence.	 Red:	 red	 channel	
showing	the	anti-OPS	immunofluorescence.	ROI:	merged	image	of	the	region	of	interest	(ROI)	for	
PCC	evaluation,	which	was	 selected	by	 free	hand	drawing	around	 the	 signal	 in	 the	 red	channel.	
Red	vs.	green:	scatterplots	of	red	and	green	pixel	intensities.	The	scatterplot	on	the	left-hand	side	
(WT)	shows	separation	of	the	green	and	red	channels	(PCC	=	0.339).	The	scatterplot	on	the	right-
hand	side	(G114D)	shows	strong	overlap	of	the	two	channels	(PCC	=	0.938).	
	 	
	5	
	
	
Figure	S4	(related	to	Figure	4).	Co-localization	analysis	of	WT	and	selected	OPS	mutants	with	the	
ER	 resident	double-stranded	RNA-activated	protein	 kinase	 (PKR)-like	 ER	 kinase	 (PERK).	 Shown	
are	representative	immunofluorescence	images,	after	expression	in	the	absence	of	retinal,	of	the	
WT,	the	WT-like	mutant	G51A,	and	the	four	mutants	T17M,	G114D,	P171Q,	and	P180A	with	the	
1D4	antibody	(red)	that	binds	an	epitope	localized	at	the	intracellular	C-term	of	OPS	and	an	anti-
PERK	antibody	(green).		These	mutants	showed	strong	CLNX	co-localization	when	expressed	in	the	
absence	 of	 retinal	 (see	 Figure	 4).	 In	 agreement	with	 the	 observations	 reported	 in	 Figure	 4	 and	
Table	S4	(showing	co-localization	analyses	with	CLNX)	WT	and	G51A	OPS	poorly	co-localized	with	
PERK	with	PCC	values	of	0.40	±	0.05	and	0.43	±	0.04	respectively,	whereas	significant	(P	≤	0.001)	
co-localization	was	observed	for	the	mutants	T17M	(PCC:	0.79	±	0.03),	G114D	(PCC:	0.80	±	0.02),	
P171Q	(PCC:	0.73	±	0.02)	and	P180A	(PCC:	0.71	±	0.03).	Scale	bar	=	50	μm.	
	
	 	
	6	
	
	
Figure	 S5	 (related	 to	 Figure	 4).	 Inverse	 correlation	 of	 plasma	membrane	 localization	 and	 ER-
retention	 of	 mutants.	 Summary	 of	 calculated	 PCC-	 and	 RetP1/1D4-values	 for	 WT	 and	 for	 all	
analyzed	mutants	expressed	 in	the	absence	(A,	C)	or	presence	 (B,	D)	of	10	μM	9-cis	 retinal.	The	
correlation	 plots	 of	 RetP1/1D4-values	 (x-axis)	 and	 PCC-values	 (y-axis)	 in	 the	 absence	 (E)	 or	
presence	 (F)	 of	 9-cis	 retinal	 are	 shown.	 Data	 represent	 the	 mean	 ±	 SE	 of	 3-5	 experiments.	
Statistical	 analyses	 for	 each	 mutant	 compared	 to	 the	 WT	 were	 performed	 by	 two-sample	 t-
Student	test.	*	P	≤	0.05;	**	P	≤	0.01;	***P	≤	0.001.	
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Figure	S6	(related	to	Figure	4).	Ability	of	the	RetP1	antibody	to	recognize	misfolded	mutant	OPS.	
Shown	 are	 representative	 immunofluorescence	 images	 of	 COS	 cells	 expressing	 WT	 and	 OPS	
mutants	 after	 permeabilization	 of	 the	 cell	 membrane	 and	 immunostaining	 with	 the	 RetP1	
antibody.	In	COS	cells	that	expressed	WT	OPS	a	uniformly	distributed	RetP1	staining	was	detected,	
independent	 of	 the	 absence	or	 presence	of	 retinal	 (+RET).	 In	 the	 case	of	mutants	 T17M,	 P23H,	
L46R,	P53R,	C110Y,	G114D,	P171Q,	Y178C,	E181K,	S186P,	C187Y,	G188R,	D190G,	D190Y,	H211P,	
H211R,	and	C222R,	that	showed	no	membrane	localization	in	the	absence		of	retinal	(see	Figure	4),	
significant	 RetP1	 staining	 around	 the	 nuclei	 was	 detected	 after	 permeabilization	 of	 the	 cell	
membrane.	 Significant	 RetP1	 staining	 of	 intracellular	 opsins	 also	 was	 detected	 with	 the	 OPS	
mutants	 L46R,	 C119Y,	 G114D,	 and	 H211R,	 after	 expression	 in	 the	 presence	 of	 retinal	 and	
permeabilization	of	the	cell	membrane.	These	mutants	showed	no	plasma	membrane	localization	
in	the	presence	of	retinal	(see	Figure	4).	Scale	bars	=	50	μm.		
	
	8	
	
	
Figure	S7	 (related	 to	Figure	4).	All-trans	 retinal	has	no	effect	on	 the	subcellular	 localization	of	
WT	OPS	and	a	subset	of	OPS	mutants.	Shown	are	representative	immunofluorescence	images	of	
WT	 OPS,	 the	 WT-like	 mutant	 G51A,	 and	 the	 three	 mutants	 T17M,	 P171Q,	 and	 P180A	 in	 the	
presence	of	10	µM	all-trans	 retinal	 (A).	CLNX/1D4:	merged	image	of	the	CLNX-	(green)	and	1D4-	
(red)	immunostaining;	RetP1:	antibody	binding	an	epitope	localized	at	the	extracellular	N-terminal	
of	OPS	allowing	detection	of	membrane	localized	OPS.	Histograms	showing	the	analyzed	PCC-	(B)	
and	RetP1/1D4	(C)	values.	WT	OPS	and	the	analyzed	mutants	showed	no	differences	in	subcellular	
localization	 in	the	absence	or	presence	of	all-trans	 retinal	confirming	that	the	responses	to	9-cis	
retinal	seen	for	T17M,	P171Q	and	P180A	(see	Figures	4	and	S6)	are	specific.	Scale	bars	=	50	μm.		
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Figure	S8	(related	to	Figure	8).	Complexes	between	the	four	distinct	optical	isomers	of	13-cis-5,8-
ERA	and	the	OPS	chromophore-binding	site.	Selected	details	of	the	interactions	between	13-cis-
5,8-ERA	 and	WT	 (A),	 T17M	 (B),	 P23H	 (C),	 and	 E181K	 (D)	 extracted	 from	 the	 average	minimized	
structures	are	shown.	For	each	mutant	OPS,	the	complexes	with	the	four	different	isomers	of	the	
ligand	are	superimposed	at	their	Cα-atoms.	The	amino	acid	side	chains	and	the	ligand	are	shown	
as	 sticks,	whereas	 the	β-hairpin	 in	EL2	 is	 shown	 in	 cartoon.	The	 ligand	 is	 colored	by	atom	 type,	
whereas	the	protein	is	colored	according	to	the	bound	isomer,	i.e.	green	for	5S8R,	yellow	for	5R8S,	
violet	for	5R8R,	and	pink	for	5S8S.	
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Figure	S9	(related	to	Figure	8).	Comparisons	between	the	binding	modes	of	the	four	isomers	of	
13-cis-5,8-ERA	and	11-cis	retinal.	Selected	details	of	the	interactions	between	13-cis-5,8-ERA	and	
T17M	(A,	D,	G,	 J),	P23H	(B,	E,	H,	K),	and	E181K	(C,	F	 I,	L)	extracted	from	the	average	minimized	
structures	are	shown.	The	ligand	is	colored	by	atom	type,	whereas	the	protein	is	colored	according	
to	the	bound	isomer,	i.e.	green	for	5S8R,	yellow	for	5R8S,	violet	for	5R8R,	and	pink	for	5S8S.	The	
complexes	 between	 each	 of	 the	 three	 OPS	 mutants	 and	 the	 ligands	 13-cis-5,8-ERA	 and	 11-cis	
retinal	(colored	blue)	are	shown	superimposed	at	the	Cα-atoms.	
The	 amino	 acid	 side	 chains	 and	 the	 ligand	 are	 shown	 as	 sticks,	whereas	 the	 β-hairpin	 in	 EL2	 is	
shown	in	cartoon.		
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Transparent	Methods	
	
In	silico	experiments	
MD	simulations	of	WT	and	adRP	mutants	in	their	OPS	and	RHO	forms	
The	 crystal	 structures	 encoded	 as	 3CAP	 (Park	 et	 al.,	 2008)	 and	 	 1GZM	 (Li	 et	 al.,	 2004)	 were	
employed	as	inputs	to	simulate,	respectively,	the	OPS	and	RHO	states	of	WT	and	33	adRP	mutants.	
The	mutants	were	selected	based	on:	(a)	their	diversified	distribution	in	the	protein	portions,	(b)	
the	 non-conservative	 nature	 of	 the	 amino	 acid	 substitution,	 and	 (c)	 previously	 reported	
biochemical	properties	(references	are	collected	in	Briscoe	et	al.,	2004,	Krebs	et	al.,	2010,	Rakoczy	
et	al.,	2011).		
The	 simulated	 structures	 of	 the	OPS	 and	RHO	 states	 are,	 respectively,	 323	 and	 326	 amino	 acid	
long;	elimination	of	the	last	three	amino	acids	served	to	reduce	the	high	mobility	of	H8	in	the	OPS	
state.	For	all	mutants	but	a	few	exceptions	(see	below)	the	native	disulphide	bridge	between	C110	
and	C187	(in	EL2)	was	set.			
Energy	minimizations	and	MD	simulations	were	carried	out	by	means	of	the	CHARMM	force	field	
(in	all-atom	mode)	(Brooks	et	al.,	2009),	using	the	GBSW	implicit	membrane/water	model	(Im	et	
al.,	 2003).	 For	 the	 11-cis	 retinal	 PSB,	 we	 employed	 the	 all-atom	 topologies	 and	 parameters	
introduced	 in	 the	 version	 c32b2	 of	 the	 force	 field.	 With	 respect	 to	 the	 physical	 parameters	
representing	the	membrane	in	the	GBSW	model,	the	surface	tension	coefficient	(representing	the	
non-polar	solvation	energy)	was	set	to	0.03	kcal/(mol.Å2).	Membrane	thickness	(centered	at	Z	=	0)	
was	set	to	30.0	Å	with	a	membrane	smoothing	length	of	5.0	Å.		
Prior	to	MD	simulations,	the	system	was	energy	minimized	by	500	steps	of	Adopted	Basis	Newton-
Raphson	(ABNR)	minimization	(Chu	et	al.,	2003).	The	minimized	coordinates	were	heated	to	300	K,	
as	well	as	 to	329	K	and	345	K	 (for	melting	 temperature	simulations	of	 the	OPS	and	RHO	states,	
respectively),	 by	 randomly	 assigning	 velocities	 from	 a	 Gaussian	 distribution.	 After	 heating,	 the	
system	 was	 allowed	 to	 equilibrate	 for	 100	 ps.	 An	 integration	 step	 of	 0.002	 ps	 was	 used.	
Equilibrium	MD	simulations	at	 the	 three	different	 temperatures	were	 carried	out	 for	10	ns.	 For	
each	 mutant	 characterized	 by	 torsion	 angles	 in	 the	 replaced	 side	 chain,	 a	 minimum	 of	 three	
rotamers	were	probed	by	MD,	corresponding	to	the	Dunbrack	and	Karplus	(D&K)	(Dunbrack	and	
Karplus,	 1993),	 Ponder	 and	 Richards	 (P&R)	 (Ponder	 and	 Richards,	 1987),	 and	 Sutcliffe	 (Sut)	
(Sutcliffe	 et	 al.,	 1987),	 rotamer	 libraries.	 Additional	 side	 chain	 conformations	 were	 probed	 by	
assigning	the	average	values	of	 the	dihedral	a	given	amino	acid	assumes	 in	the	helices	or	 in	 the	
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loops	of	 the	OPS	and	RHO	structures.	For	 the	substitutions	deprived	of	side	chain	rotamers	 (i.e.	
alanine,	glycine,	and	proline),	three	replicas	were	carried	out	by	assigning	different	random	seeds.	
In	addition	to	native	disulphide	bridge,	for	the	C110Y,	Y178C,	and	C187Y	other	disulphide	bridges	
were	probed.	These	bridges	involved	the	C185-C187	pair	for	C110Y,	the	C178-C110	or	C178-C187	
pairs	 for	 Y178C,	 and	 the	 C185-C110	 pair	 for	 C187Y.	 For	 the	 G89D,	 L125R,	 A164V,	 H211P,	 and	
H211R	mutants,	simulations	in	the	presence	of	the	native	disulphide	bridge	and	of	the	non-native	
C185-C187	bridge	were	carried	out.	Given	the	 low	resolution	of	the	 in	vitro	data	postulating	the	
formation	of	 the	non-native	bridge	 for	 such	mutants	 (Hwa	et	al.,	2001)	and	 to	 save	consistency	
with	all	the	other	cysteine-non	involving	mutants	considered	in	this	study,	we	decided	to	consider	
only	 the	 structures	holding	 the	native	bridge.	On	average,	 for	each	mutant	 in	 the	 two	different	
functional	states	(OPS	and	RHO),	considering	one	likely	prototropic	form	of	the	mutated	side	chain	
(when	applicable),	five	MD	trajectories	per	temperature	(i.e.	300	K	or	345/329	K)	were	produced	
and	subjected	to	PSN	analysis	(i.e.	on	average	100	ns	per	mutant	in	a	given	functional	state).			
The	 average	 minimized	 structures	 of	 the	 selected	 mutant	 trajectories	 at	 300	 K	 were	 used	 to	
compute	 the	 Vout	 index	 concerning	 retinal,	 by	means	 of	 the	Wordom	 software	 (Seeber	 et	 al.,	
2011).	 This	 index,	 which	 is	 the	 outer	 van	 der	 Waals	 molecular	 volume	 of	 the	 retinal	 in	 the	
structure	of	a	given	mutant	relative	to	that	in	the	structure	of	WT	RHO,	was	computed	following	
superimpositions	 of	 each	mutant	 on	 the	WT.	 	 Superimpositions	 concerned	 the	 retinal	 and	 the	
backbone	atoms	of	142	amino	acid	residues	in	the	extracellular	half	of	the	receptor.		
The	same	MD	simulation	protocol	used	for	WT	and	mutated	OPS	and	RHO	was	employed	for	the	
four	isomers	(i.e.	5S8R,	5R8S,	5R8R,	and	5S8S)	of	the	pharmacological	chaperone	discovered	in	this	
study	(i.e.	13-cis-ERA)	docked	onto	the	1GZM	structure	in	place	of	the	retinal.	The	compound	was	
parametrized	according	to	the	CHARMM	General	Force	Field.	The	WT	complexes	were	mutated	to	
produce	the	T17M,	P23H,	and	E181K	structures	used	as	well	as	inputs	of	simulations.		
	
PSN	analysis	
PSN	analyses	were	carried	out	by	means	of	the	Wordom	software	(Seeber	et	al.,	2011)	on	the	WT	
and	mutated	forms	of	OPS,	RHO,	and	the	complexes	with	13-cis-5,8-ERA.	The	PSN	implemented	in	
Wordom,	based	on	 the	approach	described	 in	 relevant	papers	by	Vishveshwara	and	 co-workers	
(Vishveshwara	et	al.,	2002,	Brinda	and	Vishveshwara,	2005),	is	a	product	of	graph	theory	applied	
to	 protein	 structures.	 A	 graph	 is	 defined	 by	 a	 set	 of	 points	 (nodes)	 and	 connections	 (edges)	
between	them.	In	a	protein	structure	graph,	each	amino	acid	is	represented	as	a	node	and	these	
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nodes	are	connected	by	edges	based	on	the	strength	of	non-covalent	interactions	between	nodes	
(Vishveshwara	et	al.,	2009).	The	strength	of	interaction	between	residues	i	and	j	(Iij)	is	evaluated	as	
a	percentage	given	by	the	following	equation:	
	 	 	 	 	 	 	 	 	 				
																																																																																																																																	
	
where	 Iij	 is	 the	percentage	 interaction	between	residues	 i	and	 j;	nij	 is	 the	number	of	atom-atom	
pairs	between	residues	i	and	j	within	a	distance	cutoff	(4.5	Å);	Ni	and	Nj	are	normalization	factors	
for	residue	types	i	and	j,	which	take	into	account	the	differences	in	size	of	the	side	chains	of	the	
different	residue	types	and	their	propensity	to	make	the	maximum	number	of	contacts	with	other	
amino	acid	residues	in	protein	structures.	The	normalization	factors	for	the	20	amino	acids	in	the	
Wordom	 implementation	were	 taken	 from	 the	work	by	Kannan	and	Vishveshwara	 (Kannan	and	
Vishveshwara,	1999),	whereas	 the	normalization	value	 for	 retinal,	 i.e.	 170.13,	was	 computed	as	
the	 average	 number	 of	 contacts	 made	 by	 the	 molecule	 in	 a	 dataset	 of	 83	 crystallographic	
structures	concerning	 the	different	photointermediate	 states	of	bacteriorhodopsin,	bovine	RHO,	
sensory	RHO,	and	squid	RHO.	The	normalization	factors	of	the	four	isomers	of	13-cis-5,8-ERA	were	
computed	as	the	average	numbers	of	contacts	made	by	the	molecule	in	10000	frames	of	the	MD	
trajectory	 of	 each	 isomer	 in	 complex	with	WT	RHO	 (i.e.	 5S8R	 =	 103.06,	 5R8S	 =	 118.67,	 5R8R	 =	
130.42,	and	5S8S	=	123.89).		
According	 to	 the	 approach,	 Iij	 is	 calculated	 for	 all	 nodes,	 excluding	 i	 ±	 n,	 where	 n	 is	 a	 given	
neighbor	cutoff,	2	 in	this	case.	An	interaction	strength	cutoff	 Imin	 is	then	chosen	and	any	residue	
pair	 ij	 for	 which	 Iij	 	 ≥	 	 Imin	 is	 considered	 to	 be	 interacting	 and	 hence	 connected	 in	 the	 protein	
structure	 graph	 (PSG).	 The	 residues	making	 four	 or	more	 edges	 are	 referred	 to	 as	 hubs	 at	 that	
particular	 Imin.	 The	 four-link	 cutoff	 relates	 to	 the	 intrinsic	 limit	 in	 the	 possible	 number	 of	 non-
covalent	connections	made	by	an	amino	acid	in	protein	structures	due	to	steric	constraints	and	it	
is	 close	 to	 its	 upper	 limit.	 Most	 amino	 acid	 hubs	 indeed	 make	 from	 4	 to	 6	 links.	 Node	 inter-
connectivity	is	finally	used	to	highlight	cluster-forming	nodes,	where	a	cluster	is	a	set	of	connected	
amino	acids	in	a	graph.		Node	clustering	procedure	is	such	that	nodes	are	iteratively	assigned	to	a	
cluster	if	they	could	establish	a	link	with	at	least	one	node	in	such	cluster.	A	node	not	linkable	to	
existing	 clusters	 initiates	a	novel	 cluster	 and	 so	on	until	 the	node	 list	 is	 exhausted.	Cluster	 size,	
defined	as	the	number	of	nodes,	varies	as	a	function	of	the	Imin,	and	the	size	of	the	largest	cluster	
is	used	to	calculate	the	Icritic	value,	which	is	worth	using	as	an	Imin	cutoff	for	the	analysis	(Brinda	and	
100×=
ji
ij
ij NN
n
I
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Vishveshwara,	2005).	An	analysis	of	200	different	proteins	showed	that,	irrespective	of	the	protein	
size	 or	 fold,	 the	 size	 of	 the	 largest	 cluster	 in	 each	 of	 the	 proteins	 undergoes	 a	 transition	 at	 a	
particular	Imin	value.	This	Imin	value	at	which	the	size	of	the	largest	cluster	decreases	dramatically	
(i.e.,	 the	midpoint	of	 the	 transition)	was	 indeed	 the	 Icritical	 (Brinda	and	Vishveshwara,	2005).	The	
latter	is	therefore	defined	as	the	Imin	at	which	the	size	of	the	largest	cluster	is	half	the	size	of	the	
largest	cluster	at	Imin	=	0.0%.	We	set	the	Imin	equal	to	the	Icritic	approximated	to	the	second	decimal	
place.	
To	compute	the	native	stable	structure	network,	the	frequencies	of	all	hubs	and	the	number	of	all	
links	in	the	300	K	network	were	averaged	with	the	frequencies	of	the	same	hubs	and	the	number	
of	links	in	the	corresponding	melting	temperature	network	(329	K	for	OPS	and	345	K	for	RHO).	In	
this	respect,	the	frequency	of	a	hub	or	link	is	the	number	of	frames	holding	the	considered	hub	or	
link	divided	by	the	total	number	of	frames	in	the	trajectory.	The	PSGs	then	served	to	quantify	the	
differences	 in	 structure	 network	 between	 WT	 and	 mutants	 through	 the	 computational	 index	
called	NP	and	described	in	the	Result	section.		
Mutants	 were	 grouped	 into	 clusters	 by	 means	 of	 the	 Partitioning	 Around	 Medoids	 (PAM)	
algorithm	(Kaufman	and	Rousseeuw,	1987)	according	to	their	pairwise	distances	defined	 in	a	3D	
coordinate	system.	In	this	coordinate	system,	each	mutant	is	indeed	described	by	a	vector	of	three	
variables:	the	NP	scores	computed	on	the	OPS	and	RHO	forms	of	each	mutant	and	the	difference	
between	them	(ΔNP).	Prior	to	cluster	analysis	the	coordinates	of	each	mutant	were	centered	by	
subtracting	 the	 variable	mean	 value.	 The	 number	 of	 clusters	 k,	 in	which	 the	 dataset	 had	 to	 be	
partitioned,	was	set	equal	to	4	according	to	the	average	Silhouette	Width	Index	(SW)	(Rousseeuw,	
1987),	which	is	a	measure	of	how	well	individual	elements	fit	into	the	assigned	cluster.	To	further	
corroborate	 the	 results	 of	 cluster	 analysis,	 other	 clustering	 algorithms	 were	 tested,	 e.g.	 the	
hierarchical	clustering	and	k-means.	A	partial	list	of	these	tests	includes:	different	ways	to	center	
and	scale	the	3D	matrix	providing	the	distances	between	mutant	pairs,	six	different	linkage	criteria	
for	 hierarchical	 agglomerative	 clustering	 and	 four	 different	 ways	 to	 calculate	 the	 difference	
between	OPS	and	RHO	NPs.	The	combination	of	all	these	variables	lead	to	more	than	100	different	
clustering	 conditions,	which	 generated	 the	 same	mutant	 partitions	when	 the	 highest	 SWi	 value	
was	used	to	select	the	number	of	clusters.	
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Virtual	screening	of	compounds	
The	over	13	million	compound	library	resulting	from	the	merger	of	the	over	17	million	compounds	
in	the	Drug-like,	Lead-like,	NCI,	and	NCIdiv	sets	from	the	ZINC	database	(http://zinc.docking.org/)	
(Irwin	 and	 Shoichet,	 2005,	 Irwin	 et	 al.,	 2012)	 were	 divided	 in	 three	 sets	 according	 to	 the	
compound	 net	 charge	 at	 physiological	 pH.	 For	 the	 present	 study,	 we	 focused	 on	 the	 set	 of	
negatively	 charged	 compounds,	whose	 chemical	 redundancy	was	minimized	 leading	 to	 a	 set	 of	
225,487	 compounds.	 Two	 different	 sets	 of	 negatively	 charged	 compounds	 (104,883	 and	 7,597)	
characterized	 by	 a	 predicted	 logP	 (i.e.	 xlogP,	 taken	 from	 the	 ZINC	 database	
(http://zinc.docking.org/))	between	5	and	7	were	prepared	as	well.	The	compound	libraries	were	
virtually	 screened	onto	 the	 retinal-binding	 sites	 of	 the	 crystal	 structures	 of	WT	OPS	 (PDB	 code:	
3CAP),	 octylglucoside	 (OG)-stabilized	 OPS	 (4J4Q),	 RHO	 (1GZM	 and	 1U19	 with	 and	 without	
structural	water	molecules).	Virtual	screening	was	carried	out	by	the	means	of	the	Glide	software	
(Friesner	et	al.,	2004,	Friesner	et	al.,	2006).	Filtering	of	the	top	1000	hits	 from	each	docking	run	
relied	on	the	docking	score	as	well	as	on	size/shape	descriptors	of	the	retinal	mimicry	potential	of	
each	compound.	The	index,	Vdif	(De	Benedetti	and	Fanelli,	2010,	Fanelli	and	De	Benedetti,	2011),	
was	computed	by	means	of	the	Wordom	software	(Seeber	et	al.,	2011)		according	to	the	following	
formula:	Vin-Vout/Vsup,	where	Vin	and	Vout	are,	respectively,	the	intersection	and	the	outer	van	
der	Waals	 volumes	 of	 each	 ligand	 in	 the	 predicted	 docking	mode	 with	 respect	 to	 the	 van	 der	
Waals	volume	of	a	reference	supermolecule	(Vsup).	In	the	present	study,	the	supermolecule	was	
11-cis	retinal	from	the	target	crystal	structure.	For	the	docking	into	the	OPS	and	OG-stabilized	OPS	
structures,	the	retinal	coordinates	extracted	from	1GZM	following	Cα-atom	superimposition	of	the	
two	proteins	were	employed	as	a	supermolecule.	Moreover,	for	these	two	target	structures,	the	
detergent	 OG	 was	 additionally	 employed	 as	 a	 supermolecule	 for	 the	 computation	 of	 the	 Vdif	
index.		
Hit	compounds	in	common	between	the	different	runs	received	priority	for	final	selection.		
A	first	selection	of	20	compounds	(Table	S7)	almost	all	characterized	by	xlogP	≥	5	out	of	a	first	list	
of	254	hits	checked	for	commercial	availability,	was	sent	to	in	vitro	testing.		
	
In	vitro	experiments		
cDNA	constructs	and	site	directed	mutagenesis	
The	 cDNA	 for	 human	 RHO	 (Angeletti	 et	 al.,	 2003)	 was	 cloned	 into	 the	 mammalian	 expression	
plasmid	 pRc/CMV	 using	 the	 HindIII/XbaI	 restriction	 sites	 (pRc/CMV-RHO).	 Site	 directed	
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mutagenesis	 was	 performed	 with	 a	 QuikChange®	 Site-Directed	 Mutagenesis	 Kit	 and	 primers	
containing	the	desired	base	change.	All	mutagenized	cDNAs	were	checked	by	sequencing.	Below	it	
is	 the	 list	 of	 mutagenized	 amino	 acids	 and	 the	 corresponding	 oligonucleotides,	 used	 for	 site	
directed	mutagenesis,	in	which	the	mutagenized	base	is	indicated	as	bold	underlined	letter:	
	
T4K	 GAATGGCAAAGAAGGCCCTAAC	
T17M	 CAATGCGATGGGTGTGGTAC	
P23H	 CAGCCACTTCGAGTACCC	
Q28H	 GAGTACCCACATTACTACCTGG	
M44T	 GCCGCCTACACGTTTCTGCTG	
F45L	 CTACATGTTGCTGCTGATCG	
L46R	 CTACATGTTTCGGCTGATCG	
G51A	 CGTGCTGGCCTTCCCCATC	
P53R	 GGGCTTCCGCATCAACTTCC	
T58R	 CAACTTCCTCCGGCTCTACGTC	
V87D	 CTTCATGGACCTAGGTGGCTTC	
G89D	 GTCCTAGATGGCTTCACCAGC	
G106R	 CTTCGTCTTCCGGCCCACAG	
C110Y	 CACAGGATACAATTTGGAGGGC	
G114D	 CAATTTGGAGGACTTCTTTGCC	
L125R	 ATTGCCCGGTGGTCCTTG	
R135W	 CCATCGAGTGGTACGTGGT	
V137M	 GCGGTACATGGTGGTGTGTA	
A164V	 GTCATGGTGCTGGCCTGCG	
C167R	 GCGCTGGCCCGCGCCGCACC	
P171Q	 CCGCACCCCAACTCGCCGGC	
Y178C	 GGTCCAGGTGCATCCCCGAG	
P180A	 CAGGTACATCGCCGAGGGCCTG	
E181K	 GTACATCCCCAAGGGCCTGCAG	
S186P	 CCTGCAGTGCCCGTGTGGAATC	
C187Y	 CAGTGCTCGTATGGAATCGAC	
G188R	 GCTCGTGTCGAATCGACTAC	
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D190G	 GGAATCGGCTACTACACGCTC	
D190Y	 TGTGGAATCTACTACTACACGCT	
H211P	 GTTCGTGGTCCCCTTCACCATCC	
H211R	 GTTCGTGGTCCGCTTCACCATCC	
C222R	 CATCTTTTTCAGGTATGGGCAGCTC	
P267L	 CTGGGTGCTCTACGCCAGCG	
	
Cell	culture	and	transfection	of	COS-7	cells		
Twenty-four	 hours	 prior	 transfection	COS-7	 cells	were	 seeded	onto	 12	mm	gelatin	 coated	 glass	
coverslips	 at	 a	 density	 of	 2x104	 cells	 per	 slide.	 Cells	 were	 transfected	 with	 WT	 and	 mutant	
pRc/CMV-RHO	constructs	by	calcium	phosphate	transfection	as	described	previously	(Graham	and	
van	der	Eb,	1973).	Briefly,	4	hours	prior	transfection	cells	were	fed	with	270	µl	of	fresh	medium.	
Plasmid	DNA	 (1	µg)	was	 resuspended	 in	13.5	µl	 sterile	water	and	1.5	µl	2.5	M	CaCl2	was	added	
(final	concentration:	250	mM).	Subsequently	the	CaCl2-DNA	mix	was	added	drop	wise	and	under	
permanent	mixing	to	15	µl	HEPES-buffered	saline	(HBS:	50	mM	HEPES,	1.5	mM	Na2HPO4,	280	mM	
NaCl,	pH	7.11).	After	incubation	for	twenty	minutes	at	room	temperature	the	DNA-CaCl2-HBS	mix	
was	 overlaid	 on	 cells.	 Twenty-four	 hours	 after	 transfection	 cells	 were	 washed	 twice	 with	
phosphate	buffered	saline	 (PBS)	and	fresh	complete	DMEM	with	or	without	10	µM	9-cis	 retinal,	
all-trans	retinal	or	new	compounds	was	added	in	the	dark.	For	calculation	of	EC50	9-cis	retinal	and	
the	 13-cis-5,8-ERA	 compound	 were	 added	 at	 different	 concentrations	 from	 0	 to	 50	 μM.	 No	
significant	differences	in	transfection	efficiencies	were	observed	with	different	constructs	(WT	or	
mutants)	and	transfected	cells	expressed	OPS	protein	of	expected	molecular	weight	as	assessed	by	
western	blotting	(Figure	S3A).	For	each	experiment	at	least	three	slides	were	analyzed	for	ER-	and	
plasma	membrane-localization	in	the	presence	and	absence	of	retinal.		
	
Immunohistochemistry		
Forty-eight	 hours	 after	 transfection	 cells	 were	 fixed	with	 2	%	 paraformaldehyde	 in	 PBS	 for	 ten	
minutes.	 For	 co-localization	 analysis	 fixed	 cells	were	permeabilized	 and	blocked	 in	 PBS	with	 3%	
BSA	and	0.1	%	TritonX-100	for	1	hour	at	room	temperature	(3%	BSA	and	0.1	%	TritonX-100	for	30	
min	 followed	 by	 3%	 BSA	 for	 additional	 30	min	 for	 anti-PERK),	 washed	 five	 times	with	 PBS	 and	
incubated	with	the	monoclonal	mouse	anti-OPS	antibody	1D4	(epitope	at	the	C-terminal	of	OPS)	
together	with	the	polyclonal	rabbit	anti-calnexin	antibody	CLNX	or	rabbit	anti-PERK	antibody	for	1	
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hour	 at	 room	 temperature.	 To	analyze	 the	membrane	 localization	of	OPS/RHO,	 fixed	 cells	were	
blocked	 in	PBS	with	3%	BSA	without	detergent	 to	 avoid	permeabilization	of	 the	 cell	membrane	
and	 incubated	 with	 the	 primary	mouse	 anti-OPS	 antibody	 RetP1	 (epitope	 at	 the	 N-terminal	 of	
OPS).	 To	 confirm	 that	 the	 RetP1	 antibody	 was	 able	 to	 detect	 wild	 type	 as	 well	 as	 mutated	
OPS/RHO	 we	 evaluated	 RetP1	 staining	 after	 permeabilization	 for	 those	 mutants	 that	 failed	 to	
show	a	signal	in	non-permeabilized	cells	(Figure	S6).	As	secondary	antibodies	Alexa	Flour	568	goat	
anti-mouse	and	Oregon-Green	488	goat	anti-rabbit	antibodies	were	used	and	0.1	µg/ml	DAPI	for	
nuclear	staining.	Slides	were	mounted	with	Mowiol	4-88	and	analyzed	with	a	Zeiss	Axioskop	40	FL	
fluorescence	microscope	equipped	with	a	digital	camera,	AxioCam,	and	AxioVision	Rel	version	4.8	
software	 for	 image	 processing.	 Confocal	 analysis	 was	 performed	 using	 a	 Leica	 laser	 confocal	
microscope	system.	
	
Digital	Image	analysis		
Image	processing,	 including	measurements	of	the	Pearson	Correlation	Coefficient	(PCC)	and	cell-
counting	was	conducted	using	the	open	source	ImageJ	v1.48	software.	Co-localization	of	the	1D4	
and	CLNX	immunofluorescence	was	evaluated	in	mononucleated	or	binucleated	cells,	without	any	
bias,	 by	 calculating	 the	PCC	which	determines	 the	 relative	 fluorescence	 intensities	 of	 the	 green	
Oregon-Green	488	(labeling	CLNX)	and	red	Alexa	Flour	568	(labeling	1D4)	 in	the	same	groups	of	
pixels	 in	a	 region	of	 interest	 (ROI)	 (Dunn	et	al.,	2011).	 Indeed,	consistency	was	 found	when	PCC	
values	were	computed	in	an	unbiased	manner,	or	on	mononucleated,	or	on	multinucleated	cells	
(Table	S9).	The	PCC-formula	for	an	image	consisting	of	a	red	and	green	channel	is	given	below:	
	
	
	
Ri and	 Gi 	 are	 the	 intensity	 values	 of	 pixels	 and	 R 	 and	 G 	 the	mean	 intensities	 of	 the	 red	 and	
green	channels	across	the	entire	ROI	respectively.		
The	 channels	 of	 single	 RGB	 images	 were	 split	 into	 grayscale	 pictures	 and	 the	 red	 and	 green	
channels	used	for	analysis.	An	ROI	 in	the	red	channel	was	created	by	 free	hand	drawing	around	
the	OPS/RHO	fluorescence	in	single	cells	and	used	for	calculating	PCC	(see	Ref.	(Dunn	et	al.,	2011)		
for	details;	Figure	S3B).	PCC	values	can	range	from	1	to	-1.	Whereas	a	value	of	1	represents	perfect	
correlation,	 value	 -1	 represents	perfect	but	 inverted	 correlation	and	 values	near	 zero	 represent	
distributions	of	fluorescent	signals	that	are	uncorrelated	with	one	another	(Dunn	et	al.,	2011).	
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The	 percentage	 of	 cells	 expressing	WT	 and	mutant	 OPS/RHO	was	 determined	 by	 counting	 the	
number	of	DAPI-stained	cells	and	 the	number	of	1D4+	 cells.	 To	evaluate	 the	percentage	of	 cells	
with	WT	and	mutant	OPS/RHO	on	the	cell	surface	the	same	procedure	was	performed	with	images	
taken	 from	 cells	 immunostained	 with	 RetP1	 without	 membrane	 permeabilization.	 For	 each	
experiment,	 the	percentage	of	 RetP1+	 divided	by	 the	percentage	of	 1D4+	 cells	 (RetP1/1D4)	was	
calculated.	The	mean	PCC-	and	RetP1/1D4-values	of	at	least	three	independent	experiments	were	
used	for	statistical	analysis	by	Student's	unpaired	t	test.	All	data	are	presented	as	mean	values	±	
standard	errors	of	the	means	(SEMs).		
For	 PCC	 computation	 on	 the	 33	 adRP	 mutants	 in	 their	 OPS	 and	 RHO	 forms,	 the	 number	 of	
analyzed	cells	was	on	average	45	±	14	per	mutant	form.		
For	 PCC-based	 EC50	 calculations,	 30	 cells	 were	 analyzed	 for	 each	 concentration	 (nine)	 of	 9-cis	
retinal	and	13-cis-5,8-ERA	on	three	mutants	(T17M,	P23H,	and	E181K).		
	
Preparation	of	opsin	membranes	
All	experimental	procedures	were	carried	out	in	a	darkroom	under	dim	red	light	(>670	nm).	Bovine	
rod	outer	segments	(ROS)	were	prepared	as	described	elsewhere	(Baker	et	al.,	2015,	Cogan	et	al.,	
1976,	Gulati	et	al.,	2017,	Okada	et	al.,	1994,	Papermaster,	1982).	ROS	were	washed	with	isotonic	
and	hypotonic	buffer	to	remove	both	soluble	and	membrane	associated	ROS	proteins	(Baker	et	al.,	
2015).	Purified	ROS	membranes	(19.3	mg	ml-1	Rh)	were	bleached	with	a	100	W	white	light	for	30	
min	in	the	presence	of	20	mM	hydroxylamine.	Bleached	ROS/opsin	membranes	then	were	washed	
six	 times	 each	 with	 35	 ml	 of	 buffer	 containing	 67	 mM	 potassium	 phosphate,	 pH	 7.0,	 1	 mM	
magnesium	acetate,	0.1	mM	EDTA	and	1	mM	dithiothreitol	to	dispose	of	excess	hydroxylamine.		
	
5,8-Epoxy-13-cis	retinoic	acid	binding	assays	with	opsin	
Opsin	membranes	 at	 the	 final	 concentration	of	 3.4	μM	were	 solubilized	 in	buffer	 containing	20	
mM	Bis-Tris-Propane,	pH	6.9,	100	mM	NaCl	and	0.1%	n-dodecyl	β-D-maltoside	(DDM).	Absorption	
spectra	of	solubilized	opsin	membranes	were	measured	with	a	Cary	50	UV-Vis	spectrophotometer	
maintained	at	 20	 °C	 (TC	125	 temperature	 controller,	Quantum	Northwest	 Inc.,	USA).	 13-cis-5,8-
ERA	was	added	to	achieve	a	final	concentration	of	37.5	μM		in	these	membranes	and	incubated	for	
15	min	 at	 20	 °C	 before	 the	 addition	 of	 9-cis	 retinal	 to	 a	 final	 concentration	 of	 7.5	 μM.	 Binding	
experiments	were	carried	out	for	25	min	and	absorption	spectra	were	measured	every	1	min.	The	
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time-dependent	absorption	spectra	were	fitted	with	an	exponential	function	wherein	the	slope	of	
the	fitting	curve	corresponded	to	the	apparent	half-life	of	iso-rhodopsin	regeneration.	
	
Tryptophan	fluorescence	spectroscopy		
To	confirm	the	binding	of	13-cis-5,8-ERA	in	the	retinal-binding	pocket	of	OPS,	quenching	of	opsin	
tryptophan	residues	was	monitored	before	and	after	treatment	with	increasing	concentrations	of	
either	13-cis-5,8-ERA	acid	or	9-cis	 retinal	 (Cogan	et	al.,	1976,	Golczak	et	al.,	2008).	Fluorescence	
was	measured	at	20	°C	with	an	L55	luminescence	spectrophotometer	(PerkinElmer	Life	Sciences,	
USA)	operating	at	excitation	wavelength	of	295	nm	and	an	emission	wavelength	range	of	300	and	
500	 nm	 (Alexander	 et	 al.,	 2017).	 The	 emission	 slit	 was	 set	 between	 5	 and	 10	 nm	 with	 an	
acquisition	 speed	 of	 300	 nm	 s-1.	 Opsin	 membranes	 at	 the	 final	 concentration	 of	 3.4	 nM	 were	
solubilized	 in	 buffer	 containing	 20	mM	Bis-Tris-Propane,	 pH	 6.9,	 100	mM	NaCl	 and	 0.1%	 DDM.	
Change	 in	 fluorescence	 (ΔF/F0;	where	ΔF	 is	 the	difference	between	the	 tryptophan	 fluorescence	
spectrum	before	(F0)	and	after	the	addition	of	ligand	at	specified	concentrations)	were	plotted	as	a	
function	 of	 the	 ligand	 concentration.	 Binding	 experiments	 with	 13-cis-5,8-ERA	 and	 9-cis	 retinal	
were	carried	out	at	a	concentration	range	of	0-102	nM	and	0-1470	nM,	respectively.	The	ligands	
were	 incubated	 for	 2	min	 before	 the	measurements.	 The	 raw	 tryptophan	 fluorescence	 spectra	
were	 corrected	 for	 background	 and	 the	 inner	 filter	 effect	 caused	 by	 the	 self-absorption	 of	
excitation	and	emission	light.	The	binding	curves	were	fitted	with	the	Hill	equation	to	obtain	EC50	
values.		
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